Navigation Links
Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKline's Avandia Increases Nine-Fold Following Publication of Meta-Analysis
Date:4/22/2008

least likely to cause weight gain, and the drug also received the third greatest number of votes for "agent with the best overall efficacy profile."

"Cardiovascular safety concerns have significantly impacted prescriptions for Avandia and created opportunities for other antidiabetic agents," said Donny Wong, Ph.D., principal analyst at Decision Resources. "Nearly three-quarters of physicians say they have switched patients to Januvia as a result of the Avandia meta-analysis, and one-third of PCPs and endocrinologists say they have switched patients to Byetta following publication of the Avandia meta-analysis. Nevertheless, Takeda's Actos will continue to be the market share leader among oral antidiabetic agents until the drug loses patent protection in 2011."

Avandia One Year Later-A Physician and Payer Perspective is based on a U.S. survey of 74 PCPs, 70 endocrinologists and 20 managed care pharmacy directors. Their responses were compared to assess similarities and differences of opinion regarding clinical, economic, and scientific factors.

About Physician & Payer Forum

Physician & Payer Forum is a primary research service from Decision Resources that offers access to high volume-prescribing physicians, specialists, and managed care organization representatives in the United States; analysis of events and survey participants' responses to them; insight into prescribing patterns; and an examination of the implications of events and issues for the pharmaceutical market.

About Decision Resources

Decision Resources (http://www.DecisionResources.com) is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

All company, brand, or product names contained in this document may be'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Wal-Mart & Nalgene Removing Toxic Bottles, Place Consumers Concerns First
2. 18th Annual Retirement Confidence Survey:(R) Workers Show Record Drop in Retirement Confidence, Health Care and Economy Are Major Concerns
3. Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves
4. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
5. Iomai Reports Going Concern Qualification in 10-K
6. CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders Equity
7. Talent Shortage Emerges as No. 1 Employer Concern: Deloitte/ISCEBS
8. National Religious Coalition Deeply Concerned by HHS Secretarys Disregard for Womens Reproductive Health
9. Project Concern International Receives a US$1 Million Grant From the Starbucks Foundations Ethos Water Fund to Provide Safe Water and Sanitation Services in Tanzania
10. Bi-Partisan Members of United States Senate Formally Raise Concerns About Proposed Cuts to Medicares Home Oxygen Benefit
11. TransUnion Addresses Ohio Attorney Generals Concerns Surrounding Non-Profit Tax-Exempt Status

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... InhibOx, a leading developer of novel and effecti...oined forces with MolPort, an innovator in rare ch... chemical trading platform and builds database of ...his database and its updates to computational chem... virtual screening procedures. Once they identify ...
(Date:12/4/2009)...Plantar fasciitis heel pain affects over two milli... therapy has been cited by the American Academy of...ion. In response to these findings, Orthotics And... therapy systems for plantar fasciitis treatment a...lint therapies. , (PRWEB)...
(Date:12/4/2009)...f., Dec. 4 Herpes zoster, also kno...ve been vaccinated against chicken pox, according ... of the Pediatric Infectious Diseases Journal. ,...tronic health records to identify more than 170,00...pox) vaccine from 2002 to 2008 in Kaiser Permanent...
(Date:12/3/2009)...With a membership increase of more than 15 percent...ly as a milestone in its history, but also as a si...ociations are experiencing a decline in membership...when trade organizations across the nation are suf... unprecedented growth, signaling that physicians s...
(Date:12/3/2009)....J., Dec. 3 The development of Uni...(UMCPP) reached a milestone today with a "topping ...me construction at the new hospital that will repl... ,, (Photo: http://www.newscom.com/cgi-bin/prn...is a steelworkers, tradition in which a steel beam...
Breaking Medicine News(10 mins):Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Florida Medical Association Marks Record Membership Growth 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4
...cardiologist from the University of Alabama, Birmi...bility trial that the drug showed no significant d... users and those taking similar drugs or placebos....t 28,000 patients, contained no evidence that Viox...
...amining the heart and making a correct diagnosis c...er than medical students, residents, and other pra...xamination and in accurately identifying abnormal ...ka M. Vukanovic-Criley, from Stanford University i...
... that smoking and drinking at an early age could l...e adverse effects of tobacco and alcohol has on ou...eading cause of cancer deaths, and doctors general... portal HealthDay News. Researchers led by Dr. ...
...ituminous coal, which is comparable to Jet A or mi...icopter jet engine and can now be used for propell...fuel scientist. // "Because the fuel is 50 p...nce and director of Penn State's Energy Institute....
...port by the UNH scientist, the beginning of 'natur... effect, which is a result of global warming, has ...hereby creating a ripple effect in all the happeni...ther Nature is increasingly getting a jumpstart on...
...an Singh has announced the launch of an ambitious ... five institutions in order to train around 5,000 ...seeks to address the inequalities in healthcare be...ti-disciplinary knowledge through a network of pub...
Other Medicine News:Health News:Could Long Tern Vioxx Users Suffer From Heart Attacks? 2Health News:Jets Can Now Be Propelled By Coal-based Fuel 2Health News:‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scienti 2Health News:‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scienti 3
(Date:12/3/2009)...NEW YORK, Dec. 3 Guidepoint Globa...nounced the launch of their Sleep Apnea Tracker, a...nd projects trends and market share in the worldwi...ker captures actual patient usage for 87 different... from 15 different equipment providers going back ...
(Date:12/3/2009)..., DOYLESTOWN, Pa., Dec. 3 /PRNewswire-FirstCall/...rporation, (Nasdaq: QGLY ) www.quigleyco.com an...valuation of its opportunities to develop prescrip...uded that it is in its best interests to focus pri... may include but are not limited to its Cold-EEZE&...
(Date:12/3/2009)..., FORT WORTH, Texas, Dec. 3 /PRNewswire-First...C Bulletin Board: WNDM), a rapidly growing provide...n agreement with the Health Industry Representativ...ndependent sales and marketing representative to m...ct within the U.S. ,, HIRA will market and sel...
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cooper Martin Unveils Innovative Stylish Recovery Clothing for Those with Limited Mobility 48188 1Cooper Martin Unveils Innovative Stylish Recovery Clothing for Those with Limited Mobility 48188 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 1Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 3Researchers work to boost effectiveness of the flu vaccine 48184 1Researchers work to boost effectiveness of the flu vaccine 48184 2Researchers work to boost effectiveness of the flu vaccine 48184 3
...rnal of Clinical Lipidology publishes largest stud.../simvastatin to statin therapies using FDA databas...creased cancer risk with ezetimibe mono and ezetim...o cancer rates of other powerful lipid-lowering st...ical Center lipid and health policy experts, was p...
...ERUSALEM, March 25 Oramed Pharmaceuticals,Inc. (O...per of oral delivery,systems, announced today that...the study, entitled, "Open Label Study to Assess t...cs (PD) of Oral Insulin Formulations,in Subjects w...nnual American,Diabetes Association,s Scientific S...
Other Medicine Technology:Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows 2Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA) 2
Optima III Noninsulated Allis Tooth Grasper, without ratchet
Optima III Noninsulated Duck-Bill Grasper, with ratchet
Uninsulated locking handle
Snap-In Snap-Out®-II Single Ring Handle, ratcheted, noninsulated handle, insulated shaft
Medicine Products: